From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Verditek: Gotcha! Lying scumbags enabled by Richard “Gollum” Gill and the inaction of the Oxymorons

By Tom Winnifrith, the Sheriff of AIM | Wednesday 7 February 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Oh dear, Oh dear as the shamed tipster “old Mother” Mike Walters used to say when one of his shite share tips went horribly wrong. Oh wait: Verditek (VDTK) was one of his shite share tips! Its shares were 20p at peak Walters enthusiasm. They are now 0.11p after an admission today that it is giving up the solar panels business and becoming a cash shell, albeit with almost no cash. The big red flag here which Walters overlooked was that Verditek repeatedly lied about contracts won to get placings away only to ‘fess up afterwards that the contracts, even those described as take or pay, had not happened. So, serial lying and thus fraud…always a bit of a red flag.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 09:26:16